Titan Biotech Ltd Half Yearly Results

Gross Sales

83.01

85.9

78.17

67.17

76.83

Excise Duty

0

0

0

0

0

Net Sales

83.01

85.9

78.17

67.17

76.83

Other Operating Income

0

0

0

0

0

Other Income

0.94

0.91

0.83

0.77

1.17

Total Income

83.95

86.81

79.01

67.94

78

Total Expenditure

67

68.22

61.57

56.2

58.28

PBIDT

16.95

18.59

17.44

11.74

19.72

Interest

0.57

0.6

0.57

0.4

0.35

PBDT

16.38

17.99

16.87

11.34

19.37

Depreciation

2.14

1.67

1.66

1.36

1.24

Minority Interest Before NP

0

0

0

0

0

Tax

3.45

3.96

3.8

2.69

4.49

Deferred Tax

0.08

0.14

-0.03

-0.05

-0.03

Reported Profit After Tax

10.7

12.22

11.44

7.35

13.68

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

13.09

12.17

12.68

8.21

16.63

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

13.09

12.17

12.68

8.21

16.63

EPS (Unit Curr.)

15.85

14.73

15.35

9.94

20.13

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.26

8.26

8.26

8.26

8.26

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.41

21.64

22.31

17.47

25.66

PBDTM(%)

-

-

-

-

-

PATM(%)

12.89

14.22

14.63

10.94

17.8